ATR: AptarGroup, Inc. - Summary | Jitta

AptarGroup, Inc.

NYSE:ATR

Price
$134.67
Loss Chance
43.1%
6.10JITTA SCORE
86.91%Over Jitta Line
Jitta Ranking
83 / 196
1,696 / 4,577
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (67)
Recent Business Performance (63)
Financial Strength (83)
Return to Shareholders (64)
Competitive Advantage (54)
Jitta Signs
Revenue and EarningConsistent
Dividend PayoutIncreasing Every Year
Interest Coverage RatioVery Good
Recent Business PerformanceEarning decline 3.81% in the last year
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
6.10
86.91%
4.00
728.67%
Metal and Glass Containers
3.62
171.27%
6.05
55.05%
6.27
16.75%
COMPANY DESCRIPTION
AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active packaging products. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup, Inc. has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. The company was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.